Funded Startups in Alpharetta
Across the 34 most recent Alpharetta entries, the largest disclosed round is Clearside Biomedical’s $65M Post-IPO Debt closed on 2022-08-08; it is far abov…
Across the 34 most recent Alpharetta entries, the largest disclosed round is Clearside Biomedical’s $65M Post-IPO Debt closed on 2022-08-08; it is far above the next-highest disclosed amounts ($150M OfficeSpace Software Private Equity on 2022-01-21 is actually higher—making $150M the largest disclosed in this list). The disclosure distribution is also uneven: several rows show “undisclosed” amounts (8 entries), while disclosed rounds range from $250K (LivFul on 2025-12-16) up to $150M (OfficeSpace Software on 2022-01-21).
Roughly the middle of the list clusters by time: multiple rounds concentrate in 2024 (for example, Tiger Technology $10M on 2024-11-19 and Synaptrix $10M on 2024-11-15; plus HIPnation $8M on 2025-07-22 sits later but keeps biotech/health themes recurring). Sector-wise, “Health Care/biotech-adjacent” appears repeatedly (e.g., HIPnation $8M on 2025-07-22; ModifyHealth $14M on 2024-12-04; ShareMD $5M on 2022-11-03; and Virios Therapeutics $2M on 2024-05-19), while a second notable thread is AI/data/analytics (Cyble $6M on 2023-11-14; aithentic $380K on 2023-10-11; Zoox Smart Data $5M on 2020-07-07). The temporal span runs from 2020-07-07 (Zoox Smart Data) to 2026-01-12 (Dogwood Therapeutics), with the most recent round dated 2026-01-12.
Most recent rounds
34 shownRelated listings
Frequently asked
Which disclosed round stands out in size, and how does it compare to the rest of the Alpharetta list?
OfficeSpace Software’s $150M Private Equity round on 2022-01-21 is the largest disclosed amount in these 34 rows, materially above other large disclosed rounds like Clearside Biomedical’s $65M (2022-08-08) and Drivetrain’s $15M (2022-10-18). Several other late-stage rounds cluster much closer to single-digit or low-double-digit millions (e.g., Tiger Technology and Synaptrix at $10M each in November 2024).
How much of the list has missing disclosure, and what does that do to comparisons?
8 of 34 entries are “undisclosed” (for example, Cloud Supply Chain Solutions on 2025-06-10 and Medicus IT on 2024-07-10), so size-based comparisons depend heavily on disclosed rows only. Among disclosed rounds, the smallest amount is $250K for LivFul on 2025-12-16, setting a lower bound that the typical $2M–$10M range often exceeds (e.g., Virios Therapeutics $2M on 2024-05-19; BlinkSky $2M on 2024-01-24).
Is there a temporal cluster in the recent years rather than a flat spread across time?
Yes, 2024 shows multiple substantial closes in close succession, including Tiger Technology $10M (2024-11-19) and Synaptrix $10M (2024-11-15), alongside Candor Technology being classified as Series B (undisclosed amount) on 2024-02-05. The list also extends to 2025 and 2026 with earlier-2024–to-late-2025 activity bridging sectors like health and IT (e.g., HIPnation $8M on 2025-07-22 and ModifyHealth $14M on 2024-12-04).
Which sector themes appear most often, based on repeated categories in the rows shown?
Health Care and biotech-adjacent entries recur across multiple years: HIPnation (Health Care) $8M on 2025-07-22, ModifyHealth (Food and Beverage but listed alongside biotech-like health activity) $14M on 2024-12-04, ShareMD (Health Care) $5M on 2022-11-03, and Virios Therapeutics (Apps) $2M on 2024-05-19. A second recurring theme is AI/analytics: Cyble $6M on 2023-11-14, aithentic $380K on 2023-10-11, and Zoox Smart Data (Data and Analytics) $5M on 2020-07-07.
Are there outliers that are very small or very large relative to the rest of the disclosed rounds?
LivFul’s $250K on 2025-12-16 is the smallest disclosed amount, while OfficeSpace Software’s $150M (2022-01-21) is the largest, creating an unusually wide disclosed spread. On the high end, Clearside Biomedical’s $65M Post-IPO Debt (2022-08-08) sits far above many other multi-million rounds such as BluePenguin Payments’ $3M (2022-06-10) and Virios Therapeutics’ $2M (2024-05-19).
What does the stage mix look like when comparing earlier rounds to later ones?
Earlier years include Private Equity and debt classifications, including OfficeSpace Software (Private Equity) $150M on 2022-01-21 and Clearside Biomedical (Post-IPO Debt) $65M on 2022-08-08, whereas later years (2024–2026) more often show “Series Unknown” or smaller disclosed rounds such as Dogwood Therapeutics (Series Unknown) $13M on 2026-01-12 and LivFul (Series Unknown) $250K on 2025-12-16.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.